Products for Research Use Only

β-Amyrin palmitate

CAT: 0804-HY-N2924-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-N2924-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
β-Amyrin palmitate shows HMG-CoA reductase inhibition[1]. And β-Amyrin palmitate has anti-diabetes mellitus activity[2].
CAS Number
5973-06-8
UNSPSC
12352211
Hazard Statement
H302, H371
Target
HMG-CoA Reductase (HMGCR)
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Cardiovascular Disease; Endocrinology
Assay Protocol
https://www.medchemexpress.com/β-amyrin-palmitate.html
Purity
98.0
Solubility
10 mM in DMSO
Smiles
C[C@]12[C@]3(C([C@@]4([H])[C@@](CC3)(CCC(C)(C4)C)C)=CC[C@]1([H])[C@@]5([C@@](C(C)([C@H](CC5)OC(CCCCCCCCCCCCCCC)=O)C)([H])CC2)C)C
Molecular Formula
C46H80O2
Molecular Weight
665.13
Precautions
H302, H371
References & Citations
[1]Maurya R, et al. β-Amyrin acetate and β-amyrin palmitate as antidyslipidemic agents from Wrightia tomentosa leaves. Phytomedicine. 2012;19 (8-9) :682-685.|[2]Nair SA, et al. Promising anti-diabetes mellitus activity in rats of β-amyrin palmitate isolated from Hemidesmus indicus roots. Eur J Pharmacol. 2014;734:77-82.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported